INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Switching IRT/RTSM Providers Shouldn't Feel Like Moving Mountains | Korio Makes It Easy
Unveil how structured, repeatable processes can turn RTSM migrations from high‑risk undertakings into predictable transitions.
-
Delivering Specialist Neurology Support
Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.
-
Why Sponsors Are Moving Away From Multi-Vendor Trial Support
Multi-vendor trial models often limit visibility and coordination. Discover how centralized operations can streamline workflows, control costs, and improve stakeholder experiences.
-
Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments
Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.
-
Successful Partnership Advances AML Program To Phase II/III10/26/2026
See how strong collaboration rescued a stalled AML study, proved a safer approach to a proven drug class, and turned a Phase I/II partnership into a global Phase II/III trial.
-
The Importance Of A Centralized Payment System In Clinical Trials12/5/2025
Adopt a centralized payment system to streamline financial workflows, enhance site satisfaction, and ensure compliance while supporting efficient, scalable clinical trials.
-
The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation5/11/2026
Clinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.
-
Launching A Unified Global Sales Team In 90 Days11/7/2025
A global CRO united 300+ sales and executive leaders across five continents for a dynamic, space-themed meeting that strengthened culture, deepened product understanding, and inspired alignment toward annual growth goals.
-
Navigating the Next Wave of CNS Development10/8/2026
Learn how advances in biomarkers, AI, digital endpoints, and translational science can support more informed strategies across CNS drug development.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With over 40 years of expertise in cold chain management and a global network of trusted partnerships, we safeguard the integrity of your ultracold supply chain, providing real-time monitoring and assurance for dependable sample storage.
-
Clinical research advances through participant insights. A patient-centered platform streamlines operations, enabling real-time feedback and communication to improve engagement and study outcomes.
-
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
-
What services are available to help you ensure continuous functional coverage, enhancing business continuity, operational efficiency, and risk mitigation?
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.